Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Retatrutide is still in Phase 3 trials, and MOTS-c is not FDA-approved
Pfeffer F, Nauck MA, Erb M, Mller T, Benz S, Hopt UT
Description (Peptide Therapy for Sexual Function, Libido Enhancement, and Arousal Response) Advanced Peptide Solution for Sexual Wellness and Desire Regulation PT-141 , also known by its generic name Bremelanotide , is a melanocortin receptor agonist developed to address hypoactive sexual desire disorder (HSDD) and sexual arousal dysfunction in both men and women
obtained from Boehringer Ingelheim, Ingelheim am Rhein, Germany)
Jan 2003;113(1):15-38
US$ 21.16
US$ 21.69
US$ 21.78
US$ 29.24
US$ 21.53
US$ 27.10
US$ 24.58
US$ 22.94
US$ 25.50
US$ 29.40
US$ 20.86
US$ 25.95
